Alnylam Pharmaceuticals, Inc.【ALNY】 株式報酬費用の推移
機能の使い方
|
（単位：千ドル）
|
株式報酬費用
|
前年比（％）
|
|
4Q25
|
71,632
|
-21.8%
|
|
3Q25
|
108,211
|
+136.2%
|
|
2Q25
|
111,680
|
+25.1%
|
|
1Q25
|
56,712
|
+25.1%
|
|
4Q24
|
91,645
|
+118.2%
|
|
3Q24
|
45,804
|
-28.4%
|
|
2Q24
|
89,288
|
+17.8%
|
|
1Q24
|
45,347
|
+13.5%
|
|
4Q23
|
41,994
|
-1.8%
|
|
3Q23
|
63,937
|
-50.1%
|
|
2Q23
|
75,802
|
+148.8%
|
|
1Q23
|
39,947
|
+36.4%
|
|
4Q22
|
42,767
|
-4.1%
|
|
3Q22
|
128,118
|
+284.0%
|
|
2Q22
|
30,471
|
-5.0%
|
|
1Q22
|
29,293
|
-47.4%
|
|
4Q21
|
44,582
|
+30.1%
|
|
3Q21
|
33,367
|
-10.5%
|
|
2Q21
|
32,078
|
-5.0%
|
|
1Q21
|
55,690
|
+61.1%
|
|
4Q20
|
34,276
|
-48.2%
|
|
3Q20
|
37,264
|
-19.0%
|
|
2Q20
|
33,755
|
+10.3%
|
|
1Q20
|
34,578
|
+7.9%
|
|
4Q19
|
66,197
|
+136.6%
|
|
3Q19
|
46,009
|
-47.7%
|
|
2Q19
|
30,603
|
+37.6%
|
|
1Q19
|
32,032
|
+63.6%
|
|
4Q18
|
27,973
|
+3.2%
|
|
3Q18
|
87,954
|
+238.9%
|
|
2Q18
|
22,241
|
-7.4%
|
|
1Q18
|
19,584
|
+24.6%
|
|
4Q17
|
27,117
|
+31.3%
|
|
3Q17
|
25,955
|
+66.6%
|
|
2Q17
|
24,030
|
+51.9%
|
|
1Q17
|
15,717
|
-33.1%
|
|
4Q16
|
20,651
|
+33.1%
|
|
3Q16
|
15,581
|
+31.5%
|
|
2Q16
|
15,816
|
+55.4%
|
|
1Q16
|
23,480
|
+185.1%
|
|
4Q15
|
15,520
|
+15.5%
|
|
3Q15
|
11,848
|
+86.5%
|
|
2Q15
|
10,179
|
+32.5%
|
|
1Q15
|
8,236
|
+47.3%
|
|
4Q14
|
13,438
|
+148.6%
|
|
3Q14
|
6,352
|
-28.2%
|
|
2Q14
|
7,680
|
+127.4%
|
|
1Q14
|
5,591
|
+81.8%
|
|
4Q13
|
5,406
|
+98.6%
|
|
3Q13
|
8,845
|
+161.2%
|
|
2Q13
|
3,377
|
+9.1%
|
|
1Q13
|
3,075
|
-2.6%
|
|
4Q12
|
2,722
|
-33.3%
|
|
3Q12
|
3,386
|
-20.5%
|
|
2Q12
|
3,096
|
-26.5%
|
|
1Q12
|
3,156
|
-23.4%
|
|
4Q11
|
4,082
|
-3.1%
|
|
3Q11
|
4,258
|
-5.6%
|
|
2Q11
|
4,214
|
-
|
|
1Q11
|
4,122
|
-
|
|
4Q10
|
4,212
|
-
|
|
3Q10
|
4,511
|
-
|